An updated third edition of this award-winning book provides a comprehensive overview of the complex associations between cannabis and mental illness. Organised into easy to navigate sections, the book has been fully revised to feature eight entirely new chapters covering important novel aspects. Marijuana and Madness incorporates new research findings on the potential use of cannabinoids, and synthetic cannabinoids, in an array of mental illnesses, balanced against the potential adverse effects. The associations between cannabis and psychosis, developing putative models of 'cannabis induced' psychosis and pathways to schizophrenia are all covered. The book importantly discusses the impact of exposure to cannabis at various stages of neurodevelopment (in utero, in childhood, and during adolescence) and it thoroughly reviews the treatments for cannabis dependence and health policy implications of the availability of increasingly high potency cannabis. This book will quickly become an essential resource for all members of the mental health team.
A fully updated third edition covering the current research and clinical aspects on the interactions between cannabis and mental illness. Extensively expanded to include new chapters on prenatal cannabis exposure, addiction genetics, cannabis withdrawal, and cannabis and sleep. Essential reading for all members of the mental health team.
Arvustused
'The 3rd edition of this authoritative book is remarkably up-to-date and reflects well the current state of play in both the neuroscience and clinical approaches at the interface between mental health and cannabis. The updated textbook covers the essentials of cannabis and health and, most importantly, policy in an integrated and impressively comprehensive manner. Each chapter includes both important recent publications as well as seminal papers, particularly important given the evolution of information on cannabis and contemporary considerations for public health. The chapters, authored by world renowned experts, are well written and I particularly liked the explicit tables/ boxes. My distinguished colleagues and friends Drs D'Souza, Castle, and Murray are to be congratulated for providing us with this outstanding, authoritative, and remarkably contemporary book on mental health and cannabis.' Peter F. Buckley, M.D., Chancellor, The University of Tennessee Health Science Center, Memphis, Tennessee 'This book clearly presents updated information on cannabis and its impact on mental illness, with a specific focus on psychotic disorders best used as a reference' Aaron John Plattner, Doody's Reviews
Muu info
A fully updated third edition of this award-winning book providing a comprehensive overview of the psychiatry and neuroscience of cannabis.
Part I. Pharmacology of Cannabis and the Endocannabinoid System:
1. How
cannabis works in the brain Ken Mackie;
2. The function of the
endocannabinoid system Nathan D. Winters and Sachin Patel;
3. Synthetic
cannabinoids Liana Fattore and Matteo Marti; Part II. The Changing Face of
Cannabis:
4. The epidemiology of cannabis use and cannabis use disorder
Deborah Hasin;
5. Is cannabis becoming more potent? Tom P. Freeman and Sam
Craft;
6. Policy implications of the evidence on cannabis use and psychosis
Wayne Hall and Louisa Degenhardt; Part III. Cannabis and the Brain:
7. The
impact of pubertal exposure to cannabis on the brain: a focus on animal
studies Erica Zemberletti and Tiziana Rubino;
8. The impact of cannabis
exposure on the adolescent brain: humans studies and translational insights
Jacqueline-Marie Ferland, Alexandra Chisholm and Yasmin L. Hurd;
9. Cannabis
and cognition: an update on short- and long-term effects Lisa-Marie
Greenwood, Valentina Lorenzetti and Nadia Solowij;
10. Is there a
cannabis-associated psychosis subtype? Lessons from biological typing in the
b-snip project, and implications for treatment Godfrey Pearlson and Matcheri
S. Keshavan; Part IV. Cannabis, Anxiety and Mood:
11. Cannabis and anxiety
Grace Lethbridge, Beth Patterson and Michael Van Ameringen;
12. Cannabis
consumption and risk of depression and suicidal behaviour Gabriella Gobbi;
13. Cannabis and bipolar disorder Jairo Pinto and Mauren Leticia Ziak; Part
V. Cannabis and Psychosis:
14. Cannabis and psychosis proneness Rajiv
Radhakrishnan, Shubham Kamal, Sinan Guloksuz and Jim van Os;
15. Which
cannabis users develop psychosis? Edoardo Spinazzola, Marta Di Forti and
Robin M. Murray;
16. Cannabis causes positive, negative, cognitive symptoms
and produces impairments in electrophysiological indices of information
processing Ashley Martin-Schnakenberg, Mohini Ranganathan and D. Cyril
D'Souza; Part VI. Cannabinoids and Schizophrenia: Aetiopathology and
Treatment Implications:
17. Does cannabis cause schizophrenia? Emmet Power,
Colm Healy, Robin M. Murray and Mary Cannon;
18. Postmortem studies of the
brain cannabinoid system in schizophrenia Suresh Sundram, Brian Dean and
David Copolov;
19. The endocannabinoid system in schizophrenia Paul Morrison;
20. Cannabidiol as a potential antipsychotic F. Markus Leweke and Cathrin
Rohleder;
21. Genetic explanations for the association between cannabis and
schizophrenia Sarah M. Colbert and Emma Johnson; Part VII. Cannabis and its
Impact on Schizophrenia:
22. Acute effects of cannabinoids in people with a
psychotic illness Suhas Ganesh, Cécile Henquet, R. Andrew Sewell, Rebecca
Kuepper, Mohini Ranganathan and Deepak Cyril D'Souza;
23. Cannabis and the
long-term course of schizophrenia Tabea SchoeleR;
24. Treating cannabis use
in schizophrenia and other psychotic disorders Alexandria S. Coles, Ashley E
Kivlichian, David J. Castle and Tony P. George; Part VIII. Special Topics:
25. Prenatal cannabis exposure: associations with development and behavior
Sarah E. Paul, Cynthia E. Rogers and Ryan Bogdan;
26. Cannabis use and
violence Giulia Trotta, Paolo Marino, Victoria Rodriguez, Robin M. Murray and
Evangelos Vassos;
27. Cannabis withdrawal Jane Metrik and Kayleigh McCarty;
28. Cannabis and addiction Valerie Curran, Will Lawn and Tom P. Freeman;
29.
Tobacco use among cannabis users: insights into co-use and why it matters for
people with psychosis Rachel A. Rabin, Erin A. McClure and Tony P. George;
30. Cannabis addiction genetics Suhas Ganesh and Arpana Agrawal;
31. Snoozing
on pot: cannabis and sleep Patrick D. Skosnik and Toral S. Surti;
32.
Cannabinoids as medicines: what the evidence says and what it does not say
Marco De Toffol, Elena Dragioti, Andre Ferrer Carvalho, and Marco Solmi.
Deepak Cyril D'Souza is Professor of Psychiatry at Yale University School of Medicine and a staff psychiatrist at VA Connecticut Healthcare System (VACHS), Connecticut. David Castle is Scientific Director of the Centre for Complex Interventions at the Centre for Addiction and Mental Health, and Professor in the Department of Psychiatry at The University of Toronto, Canada. Sir Robin Murray is Professor of Psychiatric Research at the Institute of Psychiatry (IoP) and at King's College London (KCL), and a Fellow of the Royal Society.
